Nicolas Girard is a pneumologist specializing in thoracic oncology, for the treatment of patients with lung cancer or rare thoracic cancers. He is experienced in the treatment of thymic tumors—thymomas and thymic carcinomas—as part of his work in the RYTHMIC network. He is domain leader for rare thoracic cancers for the European Reference Network EURACAN.
Nicolas Girard is involved in several clinical and translational research projects aiming at improving the treatment of these cancers. He is a member of the board of directors of the French Thoracic Cancer Intergroup. He is the Président elect of the International Thymic Malignancy Interest Group.
He is Professor of Respiratory Medicine at Versailles Saint Quentin University. He is the Head of the Curie-Montsouris Thorax Institute.